Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Early-Onset Dementia : Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. / Konijnenberg, Elles; Fereshtehnejad, Seyed-Mohammad; Kate, Mara Ten; Eriksdotter, Maria; Scheltens, Philip; Johannsen, Peter; Waldemar, Gunhild; Visser, Pieter Jelle.

I: Alzheimer Disease and Associated Disorders, Bind 31, Nr. 2, 2017, s. 146-151.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Konijnenberg, E, Fereshtehnejad, S-M, Kate, MT, Eriksdotter, M, Scheltens, P, Johannsen, P, Waldemar, G & Visser, PJ 2017, 'Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers', Alzheimer Disease and Associated Disorders, bind 31, nr. 2, s. 146-151. https://doi.org/10.1097/WAD.0000000000000152

APA

Konijnenberg, E., Fereshtehnejad, S-M., Kate, M. T., Eriksdotter, M., Scheltens, P., Johannsen, P., Waldemar, G., & Visser, P. J. (2017). Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. Alzheimer Disease and Associated Disorders, 31(2), 146-151. https://doi.org/10.1097/WAD.0000000000000152

Vancouver

Konijnenberg E, Fereshtehnejad S-M, Kate MT, Eriksdotter M, Scheltens P, Johannsen P o.a. Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. Alzheimer Disease and Associated Disorders. 2017;31(2):146-151. https://doi.org/10.1097/WAD.0000000000000152

Author

Konijnenberg, Elles ; Fereshtehnejad, Seyed-Mohammad ; Kate, Mara Ten ; Eriksdotter, Maria ; Scheltens, Philip ; Johannsen, Peter ; Waldemar, Gunhild ; Visser, Pieter Jelle. / Early-Onset Dementia : Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers. I: Alzheimer Disease and Associated Disorders. 2017 ; Bind 31, Nr. 2. s. 146-151.

Bibtex

@article{eb541ebf67034864b5b7222b58f0b8e9,
title = "Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers",
abstract = "BACKGROUND: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.METHODS: We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ({"}SveDem{"}, Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU University Medical Center).RESULTS: The frequency of EOD among all dementia patients was significantly lower in Copenhagen (410, 20%) and Stockholm (284, 21%) compared with Amsterdam (631, 48%). Not all quality indicator targets were met, such as the time to diagnosis, the mini-mental state examination score available, and the prescription of cholinesterase inhibitors. Cerebrospinal fluid sampling, registered in 2 sites, was performed in over 80% of the subjects.CONCLUSIONS: In tertiary referral centers in Copenhagen, Stockholm, and Amsterdam, quality indicators were not always met for patients with EOD. Results partly reflect differences in referral pattern, the application of diagnostic criteria, and local best practices. Standardized international procedures for patients with EOD may reduce this variability.",
keywords = "Alzheimer Disease/blood, Cholinesterase Inhibitors/therapeutic use, Europe, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Quality Indicators, Health Care/standards, Referral and Consultation",
author = "Elles Konijnenberg and Seyed-Mohammad Fereshtehnejad and Kate, {Mara Ten} and Maria Eriksdotter and Philip Scheltens and Peter Johannsen and Gunhild Waldemar and Visser, {Pieter Jelle}",
year = "2017",
doi = "10.1097/WAD.0000000000000152",
language = "English",
volume = "31",
pages = "146--151",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Early-Onset Dementia

T2 - Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

AU - Konijnenberg, Elles

AU - Fereshtehnejad, Seyed-Mohammad

AU - Kate, Mara Ten

AU - Eriksdotter, Maria

AU - Scheltens, Philip

AU - Johannsen, Peter

AU - Waldemar, Gunhild

AU - Visser, Pieter Jelle

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.METHODS: We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ("SveDem", Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU University Medical Center).RESULTS: The frequency of EOD among all dementia patients was significantly lower in Copenhagen (410, 20%) and Stockholm (284, 21%) compared with Amsterdam (631, 48%). Not all quality indicator targets were met, such as the time to diagnosis, the mini-mental state examination score available, and the prescription of cholinesterase inhibitors. Cerebrospinal fluid sampling, registered in 2 sites, was performed in over 80% of the subjects.CONCLUSIONS: In tertiary referral centers in Copenhagen, Stockholm, and Amsterdam, quality indicators were not always met for patients with EOD. Results partly reflect differences in referral pattern, the application of diagnostic criteria, and local best practices. Standardized international procedures for patients with EOD may reduce this variability.

AB - BACKGROUND: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.METHODS: We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ("SveDem", Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU University Medical Center).RESULTS: The frequency of EOD among all dementia patients was significantly lower in Copenhagen (410, 20%) and Stockholm (284, 21%) compared with Amsterdam (631, 48%). Not all quality indicator targets were met, such as the time to diagnosis, the mini-mental state examination score available, and the prescription of cholinesterase inhibitors. Cerebrospinal fluid sampling, registered in 2 sites, was performed in over 80% of the subjects.CONCLUSIONS: In tertiary referral centers in Copenhagen, Stockholm, and Amsterdam, quality indicators were not always met for patients with EOD. Results partly reflect differences in referral pattern, the application of diagnostic criteria, and local best practices. Standardized international procedures for patients with EOD may reduce this variability.

KW - Alzheimer Disease/blood

KW - Cholinesterase Inhibitors/therapeutic use

KW - Europe

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neuropsychological Tests

KW - Quality Indicators, Health Care/standards

KW - Referral and Consultation

U2 - 10.1097/WAD.0000000000000152

DO - 10.1097/WAD.0000000000000152

M3 - Journal article

C2 - 27158877

VL - 31

SP - 146

EP - 151

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 2

ER -

ID: 194915305